IL2 and familial pancreatic carcinoma: Indeed, the therapy by low-dose IL-2 or the recombinant form of IL-2 was observed as an effective approach to autoimmune conditions and inflammatory diseases [14] as well as the suppression of tumor growth in pancreatic cancer [15].